Madison-based Nimble Therapeutics is collaborating with Roche Diagnostics to discover and develop novel peptide-based molecules for diagnostics of SARS-CoV-2, the virus that causes COVID-19....
UW–Madison’s Discovery to Product (D2P) has granted $600,000 to six faculty-led research projects through the State Economic Engagement and Development (SEED) Program, funded by the State of Wisconsin....
The United State Air Force officially selected Madison’s Truax Field as one of the new homes for its new fighter jets....
In another example of ingenuity and cross-campus collaboration during a time of crisis, UW Health partnered with the UW College of Engineering to design, test and manufacture a critical piece of personal protective equipment (PPE) for frontline workers....
A COVID-19 patient at UW Hospital has received the first transfusion of plasma from a local patient who donated it since recovering from the disease....
Stadiums around the country joined the #LightItBlue campaign to support health care and essential workers around the world....
The health and safety of the people working in University Research Park is of the upmost priority. As we collectively monitor and react to the news of the spread of the novel coronavirus (COVID-19), we want to make you aware of steps University Research Park...
devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc. demonstrated the platform’s ability to predict developmental toxicity in humans with high accuracy using a cell-based test....
Never heard of Epic? Ask your doctor, because it's their software that handles the private medical records of about 60 percent of the patients in the country (including, probably, yours)....
Stemina Biomarker Discovery, Inc., today announced study results showing the high performance of the company’s Cardio quickPredict test in identifying cardiotoxic effects for a large number of well-characterized drugs....